Journal Menu► ▼ Journal Menu
Journal Browser► ▼ Journal Browser
Special Issue "Life Defense in the New Century: Natural Products in the Development of New Antimicrobial Drugs"
A special issue of Antibiotics (ISSN 2079-6382).
Deadline for manuscript submissions: closed (31 March 2023) | Viewed by 2664
Special Issue Editor
Interests: food chemistry; nutraceuticals; phytochemistry; phytocomplexes; antiaging; inflammation; antimicrobial; antiviral
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Drug resistance is a global issue concerning bacteria, yeasts, viruses, and protozoa. It is a natural phenomenon that has been enhanced by the incorrect and excessive use of antimicrobial drugs.
Today, antibiotics resistance has become an issue of large and dangerous proportions for an ever-increasing number of microbial species, with many negative impacts, not only in aspects concerning health but also those related to health expenditure. Therefore, it is necessary to identify new substances able to inhibit many microbial species, including antibiotic-resistant ones. Natural products have played a central role in many therapeutical areas, especially in infectious diseases. These compounds are characterized by a high structural heterogeneity and complexity, in addition to their ability to act on several microbial and host targets. Accordingly, this Special Issue aims at favoring scientific research in the field of natural compounds endowed with antimicrobial effects.
This may lead to the expansion of the number of compounds with antimicrobial activity against several species, including MDR microorganisms.
Studies on the effects of chemically characterized phytocomplexes and isolated compounds with antimicrobial activities will be particularly appreciated.
Dr. Matteo Micucci
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- natural compounds